Susquehanna International Group
STOK icon

Susquehanna International Group’s Stoke Therapeutics STOK Stock Holding History

Susquehanna International Group’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.87M Buy
57,291
+11,269
+24% +$370K ﹤0.01% 6333
2025
Q4 		$1.46M Buy
46,022
+19,230
+72% +$578K ﹤0.01% 6316
2025
Q3 		$630K Sell
26,792
-24,446
-48% -$419K ﹤0.01% 8442
2025
Q2 		$582K Sell
51,238
-52,541
-51% -$499K ﹤0.01% 8820
2025
Q1 		$690K Sell
103,779
-84,129
-45% -$784K ﹤0.01% 8181
2024
Q4 		$2.07M Buy
187,908
+53,767
+40% +$661K ﹤0.01% 5240
2024
Q3 		$1.65M Buy
134,141
+123,914
+1,212% +$1.76M ﹤0.01% 5692
2024
Q2 		$138K Sell
10,227
-69,299
-87% -$936K ﹤0.01% 10782
2024
Q1 		$1.07M Buy
79,526
+58,242
+274% +$353K ﹤0.01% 6719
2023
Q4 		$112K Sell
21,284
-50,957
-71% -$218K ﹤0.01% 11234
2023
Q3 		$285K Buy
72,241
+44,754
+163% +$294K ﹤0.01% 9469
2023
Q2 		$292K Buy
27,487
+11,965
+77% +$127K ﹤0.01% 9495
2023
Q1 		$129K Buy
+15,522
New +$140K ﹤0.01% 11055
2022
Q2 		– Sell
-14,409
Closed -$303K – 13904
2022
Q1 		$303K Sell
14,409
-13,681
-49% -$274K ﹤0.01% 10256
2021
Q4 		$674K Buy
28,090
+7,042
+33% +$168K ﹤0.01% 8374
2021
Q3 		$535K Buy
21,048
+9,606
+84% +$268K ﹤0.01% 9210
2021
Q2 		$385K Sell
11,442
-18,231
-61% -$644K ﹤0.01% 10225
2021
Q1 		$1.15M Buy
29,673
+22,782
+331% +$1.3M ﹤0.01% 7350
2020
Q4 		$427K Sell
6,891
-3,876
-36% -$178K ﹤0.01% 8612
2020
Q3 		$361K Buy
+10,767
New +$307K ﹤0.01% 8339
2020
Q2 		– Sell
-12,861
Closed -$305K – 10888
2020
Q1 		$295K Buy
+12,861
New +$318K ﹤0.01% 8019

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Susquehanna International Group's STOK Position: Q1 2026 in Review

Susquehanna International Group increased its Stoke Therapeutics (STOK) stake by 24% in Q1 2026, buying an estimated $370K and bringing the position to 57,291 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #6333.

Susquehanna International Group first reported a position in STOK in Q1 2020 and has held it in 21 quarters since. The position peaked at $2.07M in Q4 2024. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Susquehanna International Group held 57,291 shares of Stoke Therapeutics worth $1.87M as of Q1 2026.
  • Susquehanna International Group bought 11,269 Stoke Therapeutics shares in Q1 2026, an estimated $370K.
  • Stoke Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6333 holding.
  • Susquehanna International Group first reported a position in Stoke Therapeutics in Q1 2020 and has held it in 21 quarters since.
  • Susquehanna International Group's Stoke Therapeutics position peaked at $2.07M in Q4 2024.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.